Lawrence, United States
Rubix LS, the company founded in 2016, positions itself as "The Health Outcomes Architect Company," functioning at the intersection of Biopharma, Biotechnology, and Health Care. They focus on architecting better health outcomes by integrating diverse datasets, including clinical, biological, and socio-economic factors, into a patient-centered research framework.
Their operations are underpinned by three core pillars: Translational Bridging and Investigator-Initiated Studies, offering decision-grade evidence across translational work; Contract Research Organization (CRO) Services that support clinical research from regulatory design through execution; and partnerships with federal entities tackling public health challenges.
With access to over 25M+ patient datasets and 369M+ data points, Rubix LS leverages diverse insights, such as environmental and geographic data, to inform health outcomes. As of now, there are no disclosed investments or named investors, indicating potential for first-mover opportunities.
